Search
for
Sort by
Research 91–120 of 1000+
- Rash from EGFR inhibitors: Opportunities and challenges for palliation
- Network pharmacology-based preventive effect of XZF on cutaneous toxicities induced by EGFR inhibitor
- Tumor necrosis factor-induced alopecia: alternative pathology and therapy
- A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor
- Erosive pustular dermatosis of the scalp due to EGFR inhibitors: A multicentric study by EADV task force of ‘Dermatology for Cancer Patients’
- Folliculitis Decalvans-like Alopecia During Treatment With EGFR Inhibitors for Lung Cancer: A Case Series of 6 Patients
- 422 Human hair follicles express PD-L1, whose expression is down-regulated by EGFR and MEK inhibitors ex vivo. A potential mechanism for EGFR inhibitor induced sterile folliculitis
- Clinical development and management of adverse events associated with FGFR inhibitors
- Cutaneous side-effects of EGFR inhibitors and their management.
- Role for the Epidermal Growth Factor Receptor in Chemotherapy-Induced Alopecia
- ROCK inhibitor Y-27632 maintains the propagation and characteristics of hair follicle stem cells.
- Expression of nerve growth factor in skin tissues and its effect on the proliferation of outer root sheath cells in cashmere goats
- ISID1338 - Epidermal growth factor receptor protects from immune privilege collapse and scarring hair follicle destruction
- 1338 Epidermal growth factor receptor protects from immune privilege collapse and scarring hair follicle destruction
- New Activators and Inhibitors in the Hair Cycle Clock: Targeting Stem Cells’ State of Competence
- Hepatocyte growth factor (HGF) activator expressed in hair follicles is involved in in vitro HGF-dependent hair follicle elongation
- Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
- Factors regulating quiescent stem cells: insights from the intestine and other self-renewing tissues
- Activation of cAMP Signaling in Response to α-Phellandrene Promotes Vascular Endothelial Growth Factor Levels and Proliferation in Human Dermal Papilla Cells
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Urotensin II promotes the proliferation and secretion of vascular endothelial growth factor in rat dermal papilla cells by activating the Wnt-β-catenin signaling pathway
- 546 Epidermal growth factor receptor as a key regulator of the immune privilege
- 854 Dermal fibroblasts enhance growth factors production by androgens, and modulate keratinocyte proliferation and differentiation
- 1153 ERECTILE HEMODYNAMICS ASSESSMENT IN MEN WITH PERSISTENT ERECTILE DYSFUNCTION AFTER 5-ALPHA REDUCTASE INHIBITOR USE
- l-Ascorbic acid 2-phosphate promotes elongation of hair shafts via the secretion of insulin-like growth factor-1 from dermal papilla cells through phosphatidylinositol 3-kinase
- Scarring Alopecia in Tumor Necrosis Factor-α Antagonists-Induced Scalp Psoriasis
- Angiogenesis: a Dynamic Balance of Stimulators and Inhibitors
- Arachidonate 12-Lipoxygenase Inhibitors Promote S100A3 Citrullination in Cultured SW480 Cells and Isolated Hair Follicles
- LB1056 Phase 1b: Translational evaluation of VYN201, a pan-BD BET inhibitor, for the treatment of non-segmental vitiligo
- Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects